Kabra Drugs Ltd — Important, 06-05-2026: Company Update

Kabra Drugs has approved strategic growth initiatives. It will expand pharmaceutical manufacturing and marketing of its own generic branded formulations, starting with South India. The company is also entering AI-driven defense technologies, establishing an R&D facility in Chennai and beginning the necessary regulatory approvals. Additionally, Mr. Alagiamanavalan has been appointed as an Independent Consultant for defense projects. This move aims to diversify and position the company in high-growth sectors, strengthening operational capabilities and future readiness.